486 related articles for article (PubMed ID: 24812504)
41. Expression of Inflammatory Mediators in Induced Sputum: Comparative Study in Asthma and COPD.
Paplińska-Goryca M; Nejman-Gryz P; Górska K; Białek-Gosk K; Hermanowicz-Salamon J; Krenke R
Adv Exp Med Biol; 2018; 1040():101-112. PubMed ID: 27739024
[TBL] [Abstract][Full Text] [Related]
42. Pharmacological strategies to regain steroid sensitivity in severe asthma and COPD.
Mei D; Tan WSD; Wong WSF
Curr Opin Pharmacol; 2019 Jun; 46():73-81. PubMed ID: 31078066
[TBL] [Abstract][Full Text] [Related]
43. Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation.
Bathoorn E; Liesker JJ; Postma DS; Koëter GH; van der Toorn M; van der Heide S; Ross HA; van Oosterhout AJ; Kerstjens HA
Int J Chron Obstruct Pulmon Dis; 2009; 4():101-9. PubMed ID: 19436694
[TBL] [Abstract][Full Text] [Related]
44. Vitamin D deficiency exacerbates COPD-like characteristics in the lungs of cigarette smoke-exposed mice.
Heulens N; Korf H; Cielen N; De Smidt E; Maes K; Gysemans C; Verbeken E; Gayan-Ramirez G; Mathieu C; Janssens W
Respir Res; 2015 Sep; 16(1):110. PubMed ID: 26376849
[TBL] [Abstract][Full Text] [Related]
45. Cholinergic mechanisms in an organic dust model simulating an acute exacerbation in patients with COPD.
Palmberg L; Sundblad BM; Ji J; Karén J; Larsson K
Int J Chron Obstruct Pulmon Dis; 2018; 13():3611-3624. PubMed ID: 30464444
[TBL] [Abstract][Full Text] [Related]
46. T2 Biologics for Chronic Obstructive Pulmonary Disease.
Yousuf A; Ibrahim W; Greening NJ; Brightling CE
J Allergy Clin Immunol Pract; 2019; 7(5):1405-1416. PubMed ID: 31076058
[TBL] [Abstract][Full Text] [Related]
47. Beyond corticosteroids: future prospects in the management of inflammation in COPD.
Roche N; Marthan R; Berger P; Chambellan A; Chanez P; Aguilaniu B; Brillet PY; Burgel PR; Chaouat A; Devillier P; Escamilla R; Louis R; Mal H; Muir JF; Pérez T; Similowski T; Wallaert B; Aubier M
Eur Respir Rev; 2011 Sep; 20(121):175-82. PubMed ID: 21881145
[TBL] [Abstract][Full Text] [Related]
48. Use of inhaled corticosteroids in COPD: improving efficacy.
Yang IA; Shaw JG; Goddard JR; Clarke MS; Reid DW
Expert Rev Respir Med; 2016; 10(3):339-50. PubMed ID: 26855301
[TBL] [Abstract][Full Text] [Related]
49. Cytokines in chronic obstructive pulmonary disease.
Chung KF
Eur Respir J Suppl; 2001 Dec; 34():50s-59s. PubMed ID: 12392035
[TBL] [Abstract][Full Text] [Related]
50. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
[TBL] [Abstract][Full Text] [Related]
51. Hydrogen coadministration slows the development of COPD-like lung disease in a cigarette smoke-induced rat model.
Liu X; Ma C; Wang X; Wang W; Li Z; Wang X; Wang P; Sun W; Xue B
Int J Chron Obstruct Pulmon Dis; 2017; 12():1309-1324. PubMed ID: 28496315
[TBL] [Abstract][Full Text] [Related]
52. Change of Serum Inflammatory Cytokines Levels in Patients With Chronic Obstructive Pulmonary Disease, Pneumonia and Lung Cancer.
Chen J; Li X; Huang C; Lin Y; Dai Q
Technol Cancer Res Treat; 2020; 19():1533033820951807. PubMed ID: 33111646
[TBL] [Abstract][Full Text] [Related]
53. Translational overview of cytokine inhibition in acute myocardial infarction and chronic heart failure.
Hartman MHT; Groot HE; Leach IM; Karper JC; van der Harst P
Trends Cardiovasc Med; 2018 Aug; 28(6):369-379. PubMed ID: 29519701
[TBL] [Abstract][Full Text] [Related]
54. Simvastatin up-regulates adenosine deaminase and suppresses osteopontin expression in COPD patients through an IL-13-dependent mechanism.
Maneechotesuwan K; Kasetsinsombat K; Wongkajornsilp A; Barnes PJ
Respir Res; 2016 Aug; 17(1):104. PubMed ID: 27557561
[TBL] [Abstract][Full Text] [Related]
55. The role of thymic stromal lymphopoietin in allergic inflammation and chronic obstructive pulmonary disease.
Fang C; Siew LQ; Corrigan CJ; Ying S
Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):81-90. PubMed ID: 20143171
[TBL] [Abstract][Full Text] [Related]
56. IL-22 Defect During Streptococcus pneumoniae Infection Triggers Exacerbation of Chronic Obstructive Pulmonary Disease.
Pichavant M; Sharan R; Le Rouzic O; Olivier C; Hennegrave F; Rémy G; Pérez-Cruz M; Koné B; Gosset P; Just N; Gosset P
EBioMedicine; 2015 Nov; 2(11):1686-96. PubMed ID: 26870795
[TBL] [Abstract][Full Text] [Related]
57. Dynamics of pro-inflammatory and anti-inflammatory cytokine release during acute inflammation in chronic obstructive pulmonary disease: an ex vivo study.
Hackett TL; Holloway R; Holgate ST; Warner JA
Respir Res; 2008 May; 9(1):47. PubMed ID: 18510721
[TBL] [Abstract][Full Text] [Related]
58. New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease.
Brassington K; Selemidis S; Bozinovski S; Vlahos R
Clin Sci (Lond); 2019 Apr; 133(7):885-904. PubMed ID: 30979844
[TBL] [Abstract][Full Text] [Related]
59. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters.
Zou Y; Chen X; Liu J; Zhou DB; Kuang X; Xiao J; Yu Q; Lu X; Li W; Xie B; Chen Q
Int J Chron Obstruct Pulmon Dis; 2017; 12():1247-1254. PubMed ID: 28490868
[TBL] [Abstract][Full Text] [Related]
60. New treatments for chronic obstructive pulmonary disease.
Barnes PJ
Ann Ist Super Sanita; 2003; 39(4):573-82. PubMed ID: 15098577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
